Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Perfusion Tech ApS
APS
Active
Reklamebeskyttelse
CVR 38238213
Viborggade 70D, 2100
København Ø
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2016 · 9 years old
10 employees
perfusiontech.com
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Perfusion Tech ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (1)
DC
Declan Cassells
Management
Management
2025
Former (2)
MA
Mads Aagaard Linde Madsen
Chief Executive Officer
Chief Executive Officer
2016 – 2023
PC
Pernille Charlotte Singer
Chief Executive Officer
Chief Executive Officer
2023 – 2025
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Former (7)
LH
Lars Henning Stigel
Board of Directors
Board of Directors
2020 – 2023
SS
Sten Scheibye
Board of Directors
Board of Directors
2022 – 2025
HC
Henrik Christensen
Chairman
Chairman
2023 – 2025
JØ
Jeppe Øvli Øvlesen
Board of Directors
Board of Directors
2017 – 2025
SB
Steffen Boutrup Møller
Board of Directors
Board of Directors
2017 – 2020
TE
Thomas Engelbrecht Nordkild Jonassen
Board of Directors
Board of Directors
2017 – 2025
MA
Morten Asp Vonsild Lund
Chairman
Chairman
2017 – 2023
Aktionærer
Pr. seneste årsrapport
Shareholder
Type
Ownership
Votes
Since
Renew Pharmaceuticals Limited
Individual
100%
100%
2025
TJ Biotech Holding ApS
Company
5–9.99%
5–9.99%
2023
Uddannelses- og Forskningsstyrelsen
Company
5–9.99%
5–9.99%
2023
ASBA CONSULTING ApS
Company
15–19.99%
15–19.99%
2016
TJ BIOTECH HOLDING ApS
Company
10–14.99%
10–14.99%
2019
Quantass ApS
Company
5–9.99%
5–9.99%
2024
QUANTASS ApS
Company
10–14.99%
10–14.99%
2019
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Perfusion Tech ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network